Want to see JP:2385 full AI Analyst Report?
Soiken Holdings Inc. (2385) Stock Price & Analysis
2385 Stock Chart & Stats
- Day’s Range
- JPY 212.00 - JPY 215.00
- 52-Week Range
- JPY 182.00 - JPY 325.00
- Previous Close
- JPY 214.00
- Volume
- N/A
- Average Volume (3M)
- 513.48K
- Market Cap
- JPY 5.55B
- Enterprise Value
- -JPY 81.10M
- Total Cash (Recent Filing)
- JPY 5.26B
- Total Debt (Recent Filing)
- JPY 0
- Price to Earnings (P/E)
- 26.1
- Beta
- 0.82
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Jun 29, 2027
- Dividend Yield
- 4.72%
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet
A debt-free structure and substantial equity base provide financial resilience through operating downturns. Low leverage reduces refinancing and interest burdens, preserving flexibility to support the business and withstand weaker earnings without the added pressure of mandatory debt servicing.
Recent Cash-flow Recovery
The return to positive operating and free cash flow in the latest two years is a constructive sign that reported earnings are again being converted into cash. This improves internal funding capacity and supports confidence in near-term financial durability, despite prior volatility.
Stable Gross Margins And Renewed Profit
Relatively stable gross margins indicate that the company has retained underlying economics in its operations even as revenue weakened. The return to profitability in 2026 provides a base for recovery, although sustained improvement will depend on rebuilding the top line.
Bears Say
Sustained Revenue Contraction
Repeated revenue declines indicate weakening commercial scale rather than a single-period fluctuation. Continued contraction can reduce operating leverage, make fixed costs harder to absorb, and limit the company’s ability to sustain investment or grow earnings over the coming quarters.
Volatile Profitability
The swing from strong profitability to sizable losses and back to a modest profit demonstrates limited earnings predictability. Such volatility makes it harder to assess normalized performance, plan capital allocation, and rely on profits as a consistent source of shareholder returns.
Inconsistent Cash Generation
Cash generation has not been consistently aligned with the company’s operating performance across recent years. Multiple periods of negative operating and free cash flow reduce predictability, potentially constrain self-funded growth, and make the latest recovery less proven as a durable trend.
2385 FAQ
What was Soiken Holdings Inc.’s price range in the past 12 months?
What is Soiken Holdings Inc.’s market cap?
When is Soiken Holdings Inc.’s upcoming earnings report date?
How were Soiken Holdings Inc.’s earnings last quarter?
Is Soiken Holdings Inc. overvalued?
Does Soiken Holdings Inc. pay dividends?
What is Soiken Holdings Inc.’s EPS estimate?
How many shares outstanding does Soiken Holdings Inc. have?
What happened to Soiken Holdings Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Soiken Holdings Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Soiken Holdings Inc.
Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the creation and commercialization of cosmetics and nutritional supplements, alongside the licensing and continued development of biomarker technologies. Soiken also conducts market research and post-market surveillance specifically for dietary supplements. A key area of its work includes the research, development, and sale of functional materials like lactoferrin, as well as pharmaceuticals derived from ascochlorin. Furthermore, Soiken applies its biomarker expertise to perform clinical evaluations for food products. The company extends its services to provide vital support for physician-initiated pharmaceutical clinical research, comprehensive health screenings, and personalized health guidance. It also partners with health insurance societies to offer contracted health guidance, facilitate specialized health check-ups for dependents of the insured, and implement programs designed for diabetes prevention.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kentaro Ishigami
- Employees
- 45
- Website
- www.soiken.com
- Address
- Senri Life Science Center, Toyonaka, OS, 560-0082, JP
Soiken Holdings Inc. (2385) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |
